Hims & Hers Health (HIMS) Change in Inventory (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Change in Inventory came in at $20.3 million in Q1 2026, up 73.99% year-on-year from $11.7 million in Q1 2025, and up 176.96% quarter-over-quarter from -$26.4 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Inventory (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Change in Inventory across 7 years of filings, most recently posting $20.3 million for Q1 2026.
- Change in Inventory for Q1 2026 came in at $20.3 million, up 73.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.4 million (down 51.31% YoY), and the FY2025 annual result was $13.7 million, down 67.02% from the prior year.
- Change in Inventory came in at $20.3 million for Q1 2026 at Hims & Hers Health, up from -$26.4 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $65.7 million in Q2 2025 to a low of -$37.3 million in Q3 2025.
- The 5-year median for Change in Inventory is $2.7 million (2022), against an average of $5.0 million.
- Across the five-year window, Change in Inventory jumped 3145.13% in 2024 and plunged 556.13% in 2025, its largest moves.
- Hims & Hers Health's Change in Inventory stood at -$785000.0 in 2022, then jumped by 160.13% to $472000.0 in 2023, then surged by 3145.13% to $15.3 million in 2024, then sank by 272.23% to -$26.4 million in 2025, then surged by 176.96% to $20.3 million in 2026.
- The last three Change in Inventory figures came in at $20.3 million (Q1 2026), -$26.4 million (Q4 2025), and -$37.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -2.11 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 20.30 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 4.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.30 Mn |
| Mar 31, 2026 | 20.30 Mn |
| Dec 31, 2025 | -26.38 Mn |
| Dec 31, 2025 | -26.38 Mn |
| Sep 30, 2025 | -37.27 Mn |
| Sep 30, 2025 | -37.27 Mn |
| Jun 30, 2025 | 65.70 Mn |
| Jun 30, 2025 | 65.70 Mn |
| Mar 31, 2025 | 11.67 Mn |
| Mar 31, 2025 | 11.67 Mn |
| Dec 31, 2024 | 15.32 Mn |
| Dec 31, 2024 | 15.32 Mn |
| Sep 30, 2024 | 8.17 Mn |
| Sep 30, 2024 | 8.17 Mn |
| Jun 30, 2024 | 10.76 Mn |
| Jun 30, 2024 | 10.76 Mn |
| Mar 31, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.36 Mn |
| Dec 31, 2023 | 472,000.00 |
| Dec 31, 2023 | 472,000.00 |